KR20030092515A - Composition comprising Aneilema keisak extract for preventing and curing wart and other epidermis proliferating disease such as psoriasis, ichthyosis - Google Patents

Composition comprising Aneilema keisak extract for preventing and curing wart and other epidermis proliferating disease such as psoriasis, ichthyosis Download PDF

Info

Publication number
KR20030092515A
KR20030092515A KR1020020030202A KR20020030202A KR20030092515A KR 20030092515 A KR20030092515 A KR 20030092515A KR 1020020030202 A KR1020020030202 A KR 1020020030202A KR 20020030202 A KR20020030202 A KR 20020030202A KR 20030092515 A KR20030092515 A KR 20030092515A
Authority
KR
South Korea
Prior art keywords
extract
wart
composition
psoriasis
epidermis
Prior art date
Application number
KR1020020030202A
Other languages
Korean (ko)
Other versions
KR100484430B1 (en
Inventor
손성향
이성낙
Original Assignee
주식회사 아주의대벤쳐메딕스
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 주식회사 아주의대벤쳐메딕스 filed Critical 주식회사 아주의대벤쳐메딕스
Priority to KR10-2002-0030202A priority Critical patent/KR100484430B1/en
Publication of KR20030092515A publication Critical patent/KR20030092515A/en
Application granted granted Critical
Publication of KR100484430B1 publication Critical patent/KR100484430B1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Cosmetics (AREA)

Abstract

PURPOSE: Provided is a composition comprising an Aneilema keisak extract for preventing and treating wart and other epidermis proliferating disease such as psoriasis and ichthyosis. The composition is applied to cosmetics or pharmaceutical preparations. CONSTITUTION: A composition is characterized by comprising an Aneilema keisak extract for preventing and treating wart and other epidermis proliferating disease selected from the group consisting of psoriasis and ichthyosis. It contains the extract in the amount of 0.001-20%, based on the total weight of the composition.

Description

사마귀풀 추출물을 포함하는 사마귀,건선 및 어리선과 같은 피부 표피 증식에 의한 질환 치료 및 예방용 조성물{Composition comprising Aneilema keisak extract for preventing and curing wart and other epidermis proliferating disease such as psoriasis, ichthyosis}Composition comprising Aneilema keisak extract for preventing and curing wart and other epidermis proliferating disease such as psoriasis, ichthyosis}

본 발명은 파필로마 바이러스에 의하여 발생하는 사마귀의 생장을 억제하고, 피부 조직의 접착반 (desmosome)을 분해하는 성분을 함유하는 사마귀풀 추출물을포함하는 사마귀 치료 또는 건선 및 어린선 등 다른 피부 표피 증식에 의한 질환 치료 및 예방용 화장용 또는 약제학적 조성물에 관한 것이다.The present invention is a wart treatment or other skin epidermal proliferation including psoriasis and juvenile, including wart grass extract containing a component that inhibits the growth of warts caused by papilloma virus and decomposes the desmosome of skin tissue It relates to a cosmetic or pharmaceutical composition for the treatment and prevention of diseases by.

일반적으로 사마귀는 papova 바이러스에 속하는 DNA 바이러스 인 human papilloma virus (HPV) 에 의하여 발생하며, 손등, 손톱 주위, 입술, 혀, 귀, 코, 후두, 발바닥 등에 생긴다.In general, warts are caused by the human papilloma virus (HPV), a DNA virus belonging to the papova virus, which occurs on the back of the hand, around the nail, on the lips, tongue, ear, nose, larynx, and sole of the foot.

기존의 사마귀 치료방법은 전기소작법, 냉동요법, 산(acid), 포도필린(Podophyllin), 레이저, 5-후루로우라실(fluorouracil), DNCB 등의 방법으로 치료 할 수 있다. 전기소작법의 경우 반흔이 생기고 20-40%에서 재발하기도 한다. 25% 포도필린은 직경 3cm 이상과 점막 부위에는 사용하기 어렵다. CO2레이저는 치료율이 90% 정도이다. DNCB 치료법으로는 60% 정도의 치료율로 편평사마귀를 치료할 수 있다. 그 외에도 인터페론, 브레오마이신(bleomycin), 레티노이드(retinoids), 칸싸리딘(cantharidine),포르말린(formalin), 방사선 조사 등 여러 치료법이 있으나, 아직까지 만족할만한 약제가 개발되지 않고 있다.Conventional warts can be treated with electrocautery, cryotherapy, acid, Podophyllin, laser, 5-fururauracil, DNCB, and the like. In the case of electrocautery, scars develop and may recur in 20-40%. 25% grapefilin is difficult to use on more than 3 cm in diameter and mucosal areas. CO 2 lasers have a 90% cure rate. DNCB treatment can treat squamous warts at a 60% therapeutic rate. In addition, there are several treatments such as interferon, bleomycin, retinoids, cantharidine, formalin, and irradiation, but no satisfactory drugs have been developed.

본 발명은 상기의 문제점을 해결하고, 상기의 필요성에 의하여 안출된 것으로서, 본 발명의 목적은 사마귀, 건선 및 어린선 등 피부 표피 증식에 의한 질환 치료 및 예방용조성물을 제공하는 것이다.The present invention has been made to solve the above problems, and the object of the present invention is to provide a composition for the treatment and prevention of diseases caused by skin epidermal proliferation, such as warts, psoriasis and mammary glands.

도 1은 사마귀풀 추출물이 사마귀 조직을 분해한 사진. 도 1에서 a는 추출물 10%, b는 5%, c는 1%, d는 0.1%, e는 추출물이 포함되지 않은 배양액에서 5일 동안 배양한 것이다.1 is a photograph of the wart grass extract warts tissue. In Figure 1 a is an extract 10%, b is 5%, c is 1%, d is 0.1%, e is incubated for 5 days in a culture containing no extract.

도 2는 사마귀풀 추출물이 사마귀 조직의 접착반을 특이하게 분해하여 세포가 하나씩 떨어져나가는 전자현미경 사진. 도 2에서 a-d는 저배율(3,000배), e-h는 고배율( e,h는 20,000배, f, g는 12,000배)에서 촬영한 사진이로, a,e는 추출물 10%, b,f는 5%, c,g는 1%, d,h는 추출물이 포함되지 않은 배양액에서 5일 동안 배양한 것이다.Figure 2 is an electron micrograph of the wart grass extract specifically breaks down the adhesive plaques of the wart tissue so that cells are separated one by one. In Figure 2 ad is a low magnification (3,000 times), eh is a high magnification (e, h is 20,000 times, f, g is 12,000 times) is a photograph taken, a, e is an extract 10%, b, f is 5% , c, g is 1%, d, h is incubated for 5 days in a culture containing no extract.

상기한 목적을 달성하기 위하여 본 발명은 활성 성분으로 유효한 양의 사마귀풀 추출물을 포함하는 사마귀 및 건선 등 피부 표피 증식에 의한 질환 치료 및 예방에 효과가 있는 화장용 또는 약제학적 조성물을 제공한다.In order to achieve the above object, the present invention provides a cosmetic or pharmaceutical composition that is effective in the treatment and prevention of diseases caused by skin epidermal proliferation, such as warts and psoriasis comprising an effective amount of mole extract as an active ingredient.

본 발명은 사마귀풀 추출물이 농축하여 100배 농축액의 10% 이상에서는 사마귀풀 성분이 피부를 자극하여 문제를 일으킬 수도 있고, 0.001% 이하의 저 농도에서는 효과를 보기 어렵기 때문에 일반적인 피부외용제 중량 중에서 사마귀풀 추출물을 0.001%-20% 또는 100배 농축액을 0.2%-10% 함유하도록 하여 피부에 도포하는 것이 바람직하다.In the present invention, the mole extract may be concentrated, and the mole extract may irritate the skin at 10% or more of the 100-fold concentrate, and may cause problems at low concentrations of 0.001% or less. It is preferable to apply the extract to the skin containing 0.001% -20% or 0.2% -10% 100-fold concentrate.

사마귀풀(Aneilema keisak(Hasskarl) Hand.-Mazz) 은 외떡잎식물 분질배유목 닭의 장풀과의 한해살이풀로 습지에서 자라고 10-30cm 크기이다. 줄기 밑부분이 옆으로 뻗으면서 가지가 갈라지고 각 마디에서 수염뿌리가 나온다. 붉은빛이 섞인 자주빛을 띠며 줄기에 한 줄로 털이 난다. 잎은 어긋나고 끝이 점차 뾰족해지고 윤이 난다. 전초를 말려서 생약으로 쓸 경우에는 수죽엽, 수죽채, 죽두채 (Murdannia triguetra(Wall.) Bruckn.) 라고 부른다.Praying Mantis grass ( Aneilema keisak (Hasskarl) Hand.-Mazz) is a perennial herb of the monocotyledonous botanical chickweed, growing in marshes and 10-30 cm in size. As the base of the stem extends to the side, the branches split and a beard root comes out from each node. It is reddish purple and has a hair on the stem. The leaves are displaced and the tips are gradually pointed and shiny. When dried out herbs are used as herbal medicines, they are called Murdannia triguetra (Wall.) Bruckn.

본 발명에서 사용하는 사마귀풀 추출물로는 사마귀풀을 10-200 메쉬크기로 분쇄하여 추출용매, 바람직하게는 정제수, 에탄올, 메탄올, 부탄올, 에틸아세테이트 및 아세톤 중에서 선택된 1종 이상의 용매를 첨가하여 추출하여 이를 추출물로 이용한다.As the mantis grass extract used in the present invention, the mantis grass is ground to 10-200 mesh size and extracted by adding at least one solvent selected from an extraction solvent, preferably purified water, ethanol, methanol, butanol, ethyl acetate and acetone. It is used as an extract.

본 발명의 조성물은 비누 크림 연고 등 으로 제형화하여 사용할 수 있으며, 어떤 제형으로 사용하는가하는 것은 본 발명이 속하는 기술 분야의 당 업자에 의하여 극히 용이하게 결정될 수 있는 사항이다. 또한 본 발명의 사마귀풀 추출물은 로션, 에센스 등의 기초화장품에 편리하게 첨가하여 사마귀 치료 및 다른 피부 표피 증식에 의한 질환 (예, psoriasis, ichthyosis 등) 치료 및 예방에 사용될 수 있다.The composition of the present invention can be formulated and used in soap cream ointment, etc. Which formulation is used is a matter that can be determined very easily by those skilled in the art. In addition, the mole extract of the present invention can be conveniently added to basic cosmetics, such as lotions and essences, and can be used for the treatment and prevention of warts and other diseases caused by epidermal hyperplasia.

화장용 조성물에는 본 발명의 추출물 외에도 에멀젼 상에서는 정제수, 1가 또는 다가 알코올, 지방산 오일 및 계면활성제 등이 있고, 기타 착향제, 착색료, 방부제 등을 사용할 수 있다.In addition to the extract of the present invention, the cosmetic composition includes purified water, monohydric or polyhydric alcohols, fatty acid oils, surfactants, and the like, and other flavoring agents, coloring agents, and preservatives.

또한 가용화 상태에서는 정제수, 계면활성제, 1가 또는 다가 알코올 등이 있으며, 에멀젼 상과 같이 착향제, 착색료, 방부제 등을 사용한다.In the solubilized state, there are purified water, surfactants, monohydric or polyhydric alcohols, and the like, flavoring agents, coloring agents, and preservatives are used as in the emulsion phase.

본 발명은 액상, 크림상, 페이스트상 및 고체상 등 각각의 필요성에 따라 통상적인 제조 방법으로 어떠한 형태로든 제조할 수 있다.The present invention can be prepared in any form by conventional manufacturing methods according to the respective needs, such as liquid, cream, paste and solid phase.

이하 본 발명을 비한정적인 실시예를 통하여 더욱 상세하게 설명한다.Hereinafter, the present invention will be described in more detail with reference to non-limiting examples.

실시예 1: 사마귀풀 추출방법Example 1: Mantis grass extraction method

사마귀풀 100 그램을 물에 잘 씻은 후 물기를 제거하고 사마귀풀 무게와 동량의 물을 첨가한 다음 분쇄기 (한일 food mixer) 로 분쇄하였다. 분쇄된 사마귀풀 분쇄액을 원심분리기에서 250 xg에서 10분간 원심분리하였다. 상층액을 모아서 0.22 um pore size filter로 필터하여 불순물을 제거하고 배양액에 첨가제로 사용하였다.After 100 grams of mantis grass were washed well with water, the water was removed, the weight of the mantis grass and the same amount of water were added, and then ground with a grinder (Hanil food mixer). The ground mantis pulverized liquid was centrifuged at 250 xg for 10 minutes in a centrifuge. The supernatant was collected and filtered with a 0.22 um pore size filter to remove impurities and used as an additive to the culture.

실시예 2: 사마귀풀 추출물의 사마귀 조직 분해 실험Example 2: Wart Tissue Degradation Experiment of Mantis Grass Extract

조직 배양용 배양액을 RPMI 1640 배지를 필터로 멸균하고 소 혈청 10%, antibiotics 1% 첨가하여 조성한다음 사마귀조직을 얇게 잘라 70% 알코올에 1분간담가 두어 일반 세균을 제거하였다. 배양액 속에 10%, 5%, 1% 사마귀풀 추출물이 포함되도록 배양액을 만들고 그 속에 사마귀 조직을 담구어 37℃ 5% CO2배양기에 넣어 5일 동안 반응시켰다. 5일 후 배양 용기를 꺼내어 조직 모양의 변화를 관찰하고 사진 촬영하였다. 사마귀풀 추출물이 포함되지 않은 배양액 속에서 5일간 배양된 사마귀는 조직의 형태가 그대로 유지되는 반면에 사마귀풀 추출물이 포함된 배양액에서 배양된 사마귀는 작은 조각으로 분해되었고, 사마귀풀 추출물의 농도가 높을수록 조각이 더 작아지고 가루모양으로 분해되었다.The culture medium for tissue culture was prepared by sterilizing the RPMI 1640 medium with a filter and adding 10% bovine serum and 1% antibiotics. Then, the wart tissue was thinly cut and soaked in 70% alcohol for 1 minute to remove general bacteria. The culture solution was prepared to include 10%, 5%, and 1% wart grass extract in the culture solution, and the wart tissues were immersed therein and put into a 37 ° C. 5% CO 2 incubator for 5 days. After 5 days, the culture vessel was taken out, and the change in tissue shape was observed and photographed. Warts incubated for 5 days in a solution containing no wart extract retained their tissues, while the warts were cultured into small pieces and the concentration of the mole extract was high. The smaller the pieces, the more they were broken down into powder.

실시예 3: 사마귀풀 추출물에 의하여 분해된 사마귀 조직의 전자현미경 촬영Example 3: Electron micrographs of wart tissues degraded by wart grass extract

실시예 2에서 반응시킨 조직을 Karnovskys 고정액 (카코디레이트 버퍼내에 2% paraformaldehyde, 2% glutaraldehyde, 0.5% calcium cloride, pH 7.2)에 넣어 2시간 상온에서 고정하였다. 카코디레이트(Cacodylate) 버퍼로 2회 세척한 후 50%, 60%, 70%, 80%, 90%, 95% 100% 알코올 용액에 5분씩 담근 후 epon 혼합물에 심었다. 37℃ 6시간, 48℃ 12 시간, 60℃ 24 시간 동안 반응시켜서 블록으로 제작하였다. 이 블록을 초박절편기 (Reichert Jung Ultracut S, Leica, Vienna, Austria)로 50nm 두께로 잘라서 전자현미경 (Zeiss EM 902 A electron microscope , Leo, Oberkohen, Germany)으로 관찰하면서 사진 촬영하였다. 단단히 붙어 있던 사마귀 조직이 접착반이 분해되면서 세포가 하나하나 떨어지는 것을 확인하였다. 사마귀풀 추출물이 포함되지 않은 배양액 속에서 5일간 배양된 사마귀 조직은 세포와 세포 사이가 여전히 단단히 붙어 있고, 세포와 세포가 떨어져 나가는 경우에도 세포사이를 결합하고 있는 접착반은 그대로 유지되면서 세포가 찢어져서 떨어져 나가는 형태를 보였다. 반면에 사마귀풀 추출물이 포함된 배양액 속에서 5일간 배양된 사마귀 조직은 세포와 세포 사이를 결합하고 있는 접착반이 특이하게 녹아 내리면서 분해되어 없어지면서, 조직을 형성하던 세포가 하나씩 분리되면서 조직이 와해되는 현상이 관찰되었다. 사마귀풀 추출물의 농도가 높을수록 조직이 더 잘 와해되는 현상이 관찰되었다.The tissues reacted in Example 2 were fixed in Karnovskys fixative (2% paraformaldehyde, 2% glutaraldehyde, 0.5% calcium cloride, pH 7.2) in the cacodylate buffer and fixed at room temperature for 2 hours. After washing twice with Cacodylate buffer, it was soaked in 50%, 60%, 70%, 80%, 90%, 95% 100% alcohol solution for 5 minutes and then planted in the epon mixture. Reaction was carried out at 37 ° C. for 6 hours, 48 ° C. for 12 hours, and 60 ° C. for 24 hours to form a block. The block was cut to 50 nm thickness with an ultrathin cutting machine (Reichert Jung Ultracut S, Leica, Vienna, Austria) and photographed while observing with a microscope (Zeiss EM 902 A electron microscope, Leo, Oberkohen, Germany). The wart tissue that was firmly attached was confirmed that the cells were dropped one by one as the adhesion plate was broken down. The wart tissues cultured for 5 days in a solution containing no wart grass extract still have a firm adherence between the cells, and even when the cells fall off, the adherents that hold the cells together remain intact. It appeared to be falling apart. On the other hand, wart tissues cultured for 5 days in a solution containing wart herb extract are dissolved and dissipated by the specific melting of the adherents that bind cells to cells. Disintegration was observed. The higher the concentration of the mantis grass extract, the more the tissues disintegrated.

실시예 4: 사마귀풀 추출물을 포함하는 화장품이나 약제용 조성물의 제조예Example 4 Preparation of Cosmetic or Pharmaceutical Compositions Comprising Mantis Grass Extract

화장품 제조예: 1) 알콜상 및 수상 화장액 스킨:Cosmetic preparation example: 1) Alcohol and water cosmetic skin:

에탄올 20.00-70.00 wt%,Ethanol 20.00-70.00 wt%,

살리실산 0.10-0.50Salicylic Acid 0.10-0.50

트리클로산0.05-0.30Triclosan0.05-0.30

조합향료0.10-0.30Combination fragrances

사마귀풀 추출물 0.01-10.00Mantis Grass Extract 0.01-10.00

알란토인0.01-0.20Allantoin0.01-0.20

디포타슘글리시르히지네이트 0.01-0.10Dipotassium glycyrginate 0.01-0.10

피씨에이-아연0.01-0.10PC-Zinc0.01-0.10

1,3-부틸렌글리콜1.00-10.001,3-butylene glycol 1.00-10.00

정제수적량을 취하여 100%로 만든다.Take purified water and make 100%.

2) 알콜상 및 수상 수성 겔2) Alcohol and Water Aqueous Gels

에탄올 20.00-45.00 wt%,Ethanol 20.00-45.00 wt%,

살리실산 0.10-0.50Salicylic Acid 0.10-0.50

트리클로산0.05-0.30Triclosan0.05-0.30

캄파0.01-0.05Campa0.01-0.05

조합향료0.10-0.20Combination fragrances

카르복시비닐폴리머 0.03-1.20Carboxy vinyl polymer 0.03-1.20

트리에탄올아민 1.00-2.50Triethanolamine 1.00-2.50

사마귀풀 추출물 0.01-10.00Mantis Grass Extract 0.01-10.00

알란토인0.01-0.20Allantoin0.01-0.20

디포타슘글리시르히지네이트 0.01-0.10Dipotassium glycyrginate 0.01-0.10

피씨에이-아연0.01-0.0.05PC-Zinc0.01-0.0.05

1,3-부틸렌글리콜1.00-10.001,3-butylene glycol 1.00-10.00

정제수적량을 취하여 100%로 만든다.Take purified water and make 100%.

약제용 조성물 제조예:Examples of pharmaceutical compositions:

사마귀풀 추출액0.01-20 wt%Praying Mantis Extract0.01-20 wt%

방부제0.05-0.5Preservative 0.05-0.5

hydrophilic ointment base 79.50-99.94hydrophilic ointment base 79.50-99.94

상기와 같은 구성을 갖는 본 발명의 사마귀풀 추출물은 사마귀조직들의 분해를 촉진시켜 표피에 증식한 사마귀, 티눈 치료제, 및 건선 및 어린선 등의 치료제로 사용될 수 있다.The wart grass extract of the present invention having the configuration as described above may be used as a therapeutic agent for warts, corns, and psoriasis and young glands, which proliferate in the epidermis by promoting decomposition of wart tissues.

Claims (2)

활성성분으로 유효한 양의 사마귀풀 추출물을 포함하는 사마귀, 건선 및 어린선으로 구성된 군으로부터 선택된 하나의 피부 표피 증식에 의한 질환 치료 및 예방용 조성물.A composition for the treatment and prevention of diseases caused by epidermal proliferation of one skin selected from the group consisting of warts, psoriasis and young glands comprising an effective amount of the mole extract. 제 1 항에 있어서,The method of claim 1, 상기의 사마귀풀 추출물은 조성물 전체에 대해 조성비로 0.001%∼ 20%인 것을 특징으로 하는 조성물.The mole extract is a composition, characterized in that 0.001% to 20% by weight of the composition as a whole.
KR10-2002-0030202A 2002-05-30 2002-05-30 Composition comprising Aneilema keisak extract for preventing and curing wart and other epidermis proliferating disease such as psoriasis, ichthyosis KR100484430B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR10-2002-0030202A KR100484430B1 (en) 2002-05-30 2002-05-30 Composition comprising Aneilema keisak extract for preventing and curing wart and other epidermis proliferating disease such as psoriasis, ichthyosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR10-2002-0030202A KR100484430B1 (en) 2002-05-30 2002-05-30 Composition comprising Aneilema keisak extract for preventing and curing wart and other epidermis proliferating disease such as psoriasis, ichthyosis

Publications (2)

Publication Number Publication Date
KR20030092515A true KR20030092515A (en) 2003-12-06
KR100484430B1 KR100484430B1 (en) 2005-04-22

Family

ID=32385097

Family Applications (1)

Application Number Title Priority Date Filing Date
KR10-2002-0030202A KR100484430B1 (en) 2002-05-30 2002-05-30 Composition comprising Aneilema keisak extract for preventing and curing wart and other epidermis proliferating disease such as psoriasis, ichthyosis

Country Status (1)

Country Link
KR (1) KR100484430B1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101122733B1 (en) * 2009-03-09 2012-03-23 주식회사 아주의대벤쳐메딕스 Cosmetic for preventing and curing acnes
KR101346779B1 (en) * 2012-12-12 2014-01-03 (주) 씨유스킨 Composition for inhibiting growth or metastasis of keloids
KR20180005992A (en) * 2016-07-07 2018-01-17 한국과학기술연구원 Composition for improving wrinkle comprising Aneilema keisak Hand.-Mazz. extract and use thereof
KR20210075691A (en) * 2019-12-13 2021-06-23 한국콜마주식회사 Moisturizing composition comprising ardisia crenata extract and aneilema keisak extract as an effective ingredient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100192835B1 (en) * 1996-02-02 1999-06-15 이명환 Extracts of commelina communis which show blood glucose lowering effect
KR100307753B1 (en) * 1998-02-19 2001-11-30 조경혜 Therapeutic agent of diabetes, containing glycoprotein extracted from commelina communis l
US20020006449A1 (en) * 1998-09-21 2002-01-17 Terry James M. Method of treatment of warts and moles
KR19990007741A (en) * 1998-10-29 1999-01-25 한동규 Cancer Diagnosis and Treatment

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101122733B1 (en) * 2009-03-09 2012-03-23 주식회사 아주의대벤쳐메딕스 Cosmetic for preventing and curing acnes
KR101346779B1 (en) * 2012-12-12 2014-01-03 (주) 씨유스킨 Composition for inhibiting growth or metastasis of keloids
KR20180005992A (en) * 2016-07-07 2018-01-17 한국과학기술연구원 Composition for improving wrinkle comprising Aneilema keisak Hand.-Mazz. extract and use thereof
KR20210075691A (en) * 2019-12-13 2021-06-23 한국콜마주식회사 Moisturizing composition comprising ardisia crenata extract and aneilema keisak extract as an effective ingredient

Also Published As

Publication number Publication date
KR100484430B1 (en) 2005-04-22

Similar Documents

Publication Publication Date Title
KR20130022471A (en) Cosmetic composition comprising camellia sinensis constituents
JP3415198B2 (en) External preparation for skin
CA2357862A1 (en) Use of at least one extract from at least one plant from the ericaceae family in compositions for treating skin showing signs of old age
KR101881417B1 (en) Cosmetic composition comprising menthol, extracts of ginkgo biloba leaf, aloe barbadensis, camellia sinensis, centella asiatica and polygonum multiflorum
JP4441123B2 (en) Use of rosmarinus plant extracts in compositions for treating signs of aging skin
FR2985425A1 (en) NEW USE OF ZERUMBON
JP3407935B2 (en) External preparation for skin
KR101619571B1 (en) Anti-aging Composition for Skin External Application Comprising Magnolia Placenta Culture Extracts
JP4229305B2 (en) Hair restorer composition
JPH05339133A (en) Hair tonic for external use containing pine extract
JPH0725763A (en) Deramatic agent for external use
KR100984010B1 (en) Compound for trichogenousness and preventing the depilation
CA2461462A1 (en) Cosmetic composition for human skin and hair care
JP4707437B2 (en) Natural moisturizing factor (NMF) component production promoter
KR100484430B1 (en) Composition comprising Aneilema keisak extract for preventing and curing wart and other epidermis proliferating disease such as psoriasis, ichthyosis
JP4020284B2 (en) Hair restorer raw material and hair restorer composition
KR100348155B1 (en) The hair-growing agent composition which is contained the extract from natural phellinus linteus and preparation method using the same
KR101693923B1 (en) Anti-inflammation and Anti-aging composition for skin external application comprising Zostera marina Cell Culture Extract and Methods for preparing the Same
KR101987422B1 (en) Cosmetic composition for promoting hair growth and preventing hair loss comprising pumkin seed, phaseolus radiatus, juglans sinesis and urtica thunbergiana extract
KR102157395B1 (en) Cosmetic Composition including Rosa davurica Pall Callus Cultured in medicum containing mineral water
JP2000109417A (en) Cosmetic for improving somber color
KR20210056461A (en) Essence composition containing hibiscus sabdariffa flower extract and the mask pack comprising thereof
JP2005232163A (en) Depilation accelerating agent, depilation accelerating composition, and depilation accelerating method
JPH11335293A (en) Cell activator, preparation of cell activator and skin lotion
KR101776587B1 (en) Composition for preventing hair loss and promoting hair growth comprising an extract of Impatiens textori Miquel

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130228

Year of fee payment: 9

FPAY Annual fee payment

Payment date: 20140325

Year of fee payment: 10

FPAY Annual fee payment

Payment date: 20150309

Year of fee payment: 11

FPAY Annual fee payment

Payment date: 20160412

Year of fee payment: 12

FPAY Annual fee payment

Payment date: 20170508

Year of fee payment: 13

FPAY Annual fee payment

Payment date: 20180406

Year of fee payment: 14

FPAY Annual fee payment

Payment date: 20190410

Year of fee payment: 15